Global Kaletra Campaign
A worldwide campaign to expand access to a vital HIV treatment
On November 10, public health groups in a dozen countries launched a global campaign to challenge Abbott Laboratories’ monopolistic hold on Kaletra (lopinavir+ritonavir), a critical HIV/AIDS medicine. The goal is to spur competition by generic drugmakers and thereby lower the medicine’s price, as well as to free up its components for new and improved combination treatments.
The new campaign comprises an unprecedented global effort to fight Big Pharma’s political power and improve access to lifesaving medicines
NEW! COMPULSORY LICENSING AND THE KALETRA CAMPAIGN
PRESS RELEASE (November 9, 2011) English | Español | Chinese
SUMMARY OF ACTIONS (Please find further information on each country page)
THE 19TH INTERNATIONAL AIDS CONFERENCE (July 22nd to July 27th, 2012)